Some companies list on stock exchanges in other countries to increase market capital and to work around regulatory barriers. Investment initially from wealthy private individuals and increasingly from institutional investors is funding the growth of a number of companies. The biggest challenge for global multinational companies is to secure the raw material i.e. the cannabis plant since large scale cultivation to meet the huge demands of these companies and their customers is just starting to come about. There is a huge shortage of good quality cannabis on a large scale due to the legal status of the plant and the continued war on the plant by governments and law enforcement bodies. Besides the challenges of securing a steady and sufficient supply of cannabis, companies face local challenges in the form of myriad local cannabis laws which differ from country to country, state to state and even county to county. Mergers and acquisitions are happening at a rapid rate fueling the inorganic growth of some of the biggest companies in the last few years.
The emergence of global cannabis companies is in one way the emergence of cannabis as another big business with its associated downsides. Global cannabis companies, lobbying governments to secure their positions, are a threat to small growers and businesses, as these companies hold the muscle power to pay their way through expensive barriers. They also threaten to take away the produce from economically poorer countries and deliver them to the wealthy countries, mostly in Europe such as Germany, Switzerland and Italy, North America and Oceania, that don't cultivate the plant, but consume it in huge quantities. These companies package cannabis in such a way that the general public remains largely unaware of what is going on. Almost all global cannabis companies are currently dealing in pharmaceutical products i.e. supplying for the medical cannabis industry. Working with politicians and the medical industry, they create the image that the natural plant is evil and should remain prohibited, while their products somehow remove the harmful aspects and deliver a safe and effective product. This positioning enables them to price their products at rates catering to the wealthy classes of society, rates that the general public cannot afford, rates that contribute handsomely to the company's revenues. Basically global cannabis companies today are essentially the cannabis arm of big pharma, catering to the needs of the rich and wealthy who combined together the world over to bring about cannabis prohibition, and to take it out of the reach of the original consumers - the poor, the working classes and the religious mendicants of the world.
A balance needs to be struck between global cannabis companies, and small growers and businesses, so that these companies do not develop into another big business, with unfair practices monopolizing the cannabis industry, pushing out the small farmer, eliminating indigenous varieties of cannabis, patenting certain varieties of the plant, taking away the plant from the people who need it the most i.e. the poorest, the minorities, the indigenous communities, the elderly, the youth, the ill and women. The last thing that the world needs now is another big business like pharmaceuticals and petrochemicals, following unsustainable ways of functioning and destroying the planet all over again in the name of business, and that too using one of the most sustainable plants on earth, a plant that is a potential solution for our modern day ills. The countries that were instrumental in bringing about the prohibition of cannabis world wide, and taking the plant away from the reach of the majority of the world's human population, the UK, USA and Canada, are the ones who have a head start in the global cannabis business, along with the Netherlands, Denmark and Israel. The rest of the countries slumber on and jail their growers. How global cannabis companies operate and how the balance is struck between supply and demand, access and equity is to be seen in the coming years. For now, it appears that the early birds have got the worms, with the early movers from Canada, the Netherlands and Israel having their global cannabis companies well on the road to business glory.
Related articles
The following set of articles related to the subject are taken from various media. Words in italics are the thoughts of yours truly at the time of reading the article.'Canadian cannabis companies have picked up the pace to position themselves in the fast-growing markets south of the border – with a number of the deals essentially a wager that the United States will soon legalize marijuana.
The recent deals add up to hundreds of millions of dollars and include:
- Options to acquire equity in midsized U.S. multistate operators.
- The acquisition of a marijuana company’s debt.
- Purchases of CBD companies.
- Strategic partnerships.'
https://mjbizdaily.com/canadian-cannabis-producers-speed-entry-into-us-via-high-stakes-wagers/
The recent deals add up to hundreds of millions of dollars and include:
- Options to acquire equity in midsized U.S. multistate operators.
- The acquisition of a marijuana company’s debt.
- Purchases of CBD companies.
- Strategic partnerships.'
https://mjbizdaily.com/canadian-cannabis-producers-speed-entry-into-us-via-high-stakes-wagers/
'The Canadian cannabis industry is becoming more fragmented than ever, with the biggest licensed producers continuing to lose market share as a whole, according to a report by Bank of Montreal analyst Tamy Chen.
Citing data from analytics firm Hifyre, the report notes that the top five licensed producers represented less than 40% of the Canadian market in August, down substantially from a year ago when the producers accounted for more than half of all retail sales.
Similarly, the top nine cannabis producers accounted for almost 80% of the market last year, but that has fallen to a combined 62%.
The fragmentation comes despite month after month of record sales across Canada and significant spending on mergers and acquisitions this year, including the blockbuster combination of Tilray and Aphria.'
https://mjbizdaily.com/canadian-cannabis-industry-increasingly-fragmented-despite-ma/
Citing data from analytics firm Hifyre, the report notes that the top five licensed producers represented less than 40% of the Canadian market in August, down substantially from a year ago when the producers accounted for more than half of all retail sales.
Similarly, the top nine cannabis producers accounted for almost 80% of the market last year, but that has fallen to a combined 62%.
The fragmentation comes despite month after month of record sales across Canada and significant spending on mergers and acquisitions this year, including the blockbuster combination of Tilray and Aphria.'
https://mjbizdaily.com/canadian-cannabis-industry-increasingly-fragmented-despite-ma/
'Aurora was among companies from Australia, Canada, Israel and the United Kingdom chosen to provide products, in partnership with French pharmaceutical distributors, for up to 3,000 patients.
The medical marijuana is being supplied by participating companies at their own cost, and neither the government nor patients will have to pay for it.
“The first prescriptions of dried medical cannabis as part of the French pilot program are a significant step toward providing access to patients and will support the destigmatization of medical cannabis in France,” Aurora CEO Miguel Martin said in a statement.'
https://mjbizdaily.com/aurora-sends-first-shipment-of-free-cannabis-to-france/
The medical marijuana is being supplied by participating companies at their own cost, and neither the government nor patients will have to pay for it.
“The first prescriptions of dried medical cannabis as part of the French pilot program are a significant step toward providing access to patients and will support the destigmatization of medical cannabis in France,” Aurora CEO Miguel Martin said in a statement.'
https://mjbizdaily.com/aurora-sends-first-shipment-of-free-cannabis-to-france/
'Since Germany’s Cannabis as Medicines Act was enacted in March 2017, the country has relied exclusively on imports to meet the growing medical demand currently estimated at well over 100,000 patients. Tilray’s ongoing domestic harvest and production will play an indispensable role in ensuring that patient needs are met with products of the highest quality medical cannabis while at the same time reducing dependence on imported supply. '
https://www.businesswire.com/news/home/20210707005512/en/Tilray
https://www.businesswire.com/news/home/20210707005512/en/Tilray
' At Merida, it is our belief that the market is in fact far larger than most predictions; we see the market potentially hitting $1 trillion in global economic impact by 2027. ‘Total economic impact’ includes cannabis sales, cannabis derivatives (like isolated cannabinoids or terpenes) hemp-based CBD products, the ancillary spending on cannabis/hemp-related activity, and the cost to regulate the industries. Pause to consider: a $1 trillion market in 8 years while currently there is not a single company in the space that generates anywhere close to $500 million in revenue. That fragmentation, and the wholly unique phenomenon that a black market with an existing – and massive – consumer and patient base is transitioning to a regulated market, is what makes cannabis such a compelling opportunity.'
https://www.lidoconsulting.com/size-matters-the-total-addressable-market-of-cannabis-hemp-is-far-bigger-than-analyst-predictions/
https://www.lidoconsulting.com/size-matters-the-total-addressable-market-of-cannabis-hemp-is-far-bigger-than-analyst-predictions/
'Florida-based Trulieve Cannabis announced an agreement to acquire Arizona-headquartered Harvest Health & Recreation in an all-stock deal valued at about $2.1 billion and touted as the largest U.S. marijuana transaction to date.
The combined multistate marijuana operator will operate in 11 states, with a total of 22 growing and processing facilities and 126 medical and recreational cannabis dispensaries stretching across the Southeast, Northeast and Western United States.
In a Monday morning news release, the companies said the blockbuster deal will create the nation’s largest cannabis company based on their combined retail and cultivation footprint'
https://mjbizdaily.com/marijuana-mso-trulieve-buying-harvest-health-in-2-1-billion-mega-deal/
'Multinational tobacco company Philip Morris International reportedly is analyzing the marijuana industry for its market possibilities but hasn’t yet determined its next move.
The New York-based cigarette maker told Bloomberg News that it is looking at the potential pharmaceutical and consumer plays and assessing such factors as cannabis benefits and risks.
“We are doing all this work and will determine one day what avenues to pursue,” Chief Executive Officer Andre Calantzopoulos told Bloomberg in an interview.'
https://mjbizdaily.com/tobacco-giant-philip-morris-eyes-marijuana-market-opportunities/
The combined multistate marijuana operator will operate in 11 states, with a total of 22 growing and processing facilities and 126 medical and recreational cannabis dispensaries stretching across the Southeast, Northeast and Western United States.
In a Monday morning news release, the companies said the blockbuster deal will create the nation’s largest cannabis company based on their combined retail and cultivation footprint'
https://mjbizdaily.com/marijuana-mso-trulieve-buying-harvest-health-in-2-1-billion-mega-deal/
'Multinational tobacco company Philip Morris International reportedly is analyzing the marijuana industry for its market possibilities but hasn’t yet determined its next move.
The New York-based cigarette maker told Bloomberg News that it is looking at the potential pharmaceutical and consumer plays and assessing such factors as cannabis benefits and risks.
“We are doing all this work and will determine one day what avenues to pursue,” Chief Executive Officer Andre Calantzopoulos told Bloomberg in an interview.'
https://mjbizdaily.com/tobacco-giant-philip-morris-eyes-marijuana-market-opportunities/
'Planet 13 Holdings Inc. (CSE:PLTH)(OTCQB:PLNHF) ("Planet 13" or the "Company"), a leading vertically-integrated Nevada cannabis company, announces record sales day on April 20, 2021 ("420"). The Company generated ~US$543,000 in single-day sales with gross margins during the month in excess of 50%.'
https://irdirect.net/prviewer/release_only/id/4699525
'“The European cannabis market has the potential to exceed the U.S. cannabis market over the long-term and will help fuel our growth for years.”
According to the Financial Times, Curaleaf was making 90% of its revenues from medical marijuana at the start of 2020, but today that split has shifted, with 60% of the company’s revenues coming from adult-use cannabis.
Similar moves to legalize recreational cannabis are expected across Europe in coming years, as various countries roll back marijuana prohibition and become more accepting of cannabis in general.
Costanzo said he believes most of Europe is about three to four years behind the U.S. on that front.'
https://mjbizdaily.com/curaleaf-acquires-emmac-life-sciences-enters-european-marijuana-market/
https://irdirect.net/prviewer/release_only/id/4699525
'“The European cannabis market has the potential to exceed the U.S. cannabis market over the long-term and will help fuel our growth for years.”
According to the Financial Times, Curaleaf was making 90% of its revenues from medical marijuana at the start of 2020, but today that split has shifted, with 60% of the company’s revenues coming from adult-use cannabis.
Similar moves to legalize recreational cannabis are expected across Europe in coming years, as various countries roll back marijuana prohibition and become more accepting of cannabis in general.
Costanzo said he believes most of Europe is about three to four years behind the U.S. on that front.'
https://mjbizdaily.com/curaleaf-acquires-emmac-life-sciences-enters-european-marijuana-market/
'“We started to deliver to the first pharmacies who ordered the product from us,” Yvonne Moeller, the company’s director of communications for Europe, told Marijuana Business Daily via email.
She said more than 150 pharmacies have the products, which were made at Aurora Nordic in Denmark.
“Last week, the (first) medical cannabis products ‘Made in Denmark’ reached German pharmacies,” Aurora Deutschland GmbH announced on LinkedIn.
The move is part of Aurora’s plan to meet demand in the EU using its European-based production.'
https://mjbizdaily.com/aurora-says-its-danish-cannabis-has-reached-german-pharmacies/
She said more than 150 pharmacies have the products, which were made at Aurora Nordic in Denmark.
“Last week, the (first) medical cannabis products ‘Made in Denmark’ reached German pharmacies,” Aurora Deutschland GmbH announced on LinkedIn.
The move is part of Aurora’s plan to meet demand in the EU using its European-based production.'
https://mjbizdaily.com/aurora-says-its-danish-cannabis-has-reached-german-pharmacies/
'Andrew Livingston, director of economics and research for Denver-based cannabis law firm Vicente Sederberg, said: “I think cannabis companies have used this time to focus on their core competencies, states where they have the best business operations (and growth opportunities).”
Critical to the strong sales performance is that states generally declared cannabis as an “essential business” during the pandemic.
Livingston said it might be impossible to know if any industry is totally recession-proof, and certainly the coronavirus-spurred recession is unique.
“But what I think it shows more than anything for cannabis consumers is that cannabis is a staple commodity in their lives,” Livingston said. “Legal cannabis and good Netflix.”'
https://mjbizdaily.com/growing-marijiuana-markets-lift-earnings-for-multistate-operators/
'When announcing the close of its acquisition of Grassroots in July, Curaleaf proclaimed that it would create the largest cannabis company in the world.
Curaleaf already is at the top of the heap of U.S. marijuana MSOs, posting $121.4 million of revenue in the second quarter ended June 30.
Florida-based Trulieve and Illinois-based Green Thumb Industries were in almost identical territory, however, with $120.8 million and $119.6 million in revenue, respectively.'
https://mjbizdaily.com/curaleaf-rises-to-the-top-of-us-marijuana-industry-with-footprint-covering-about-two-dozen-states/
Critical to the strong sales performance is that states generally declared cannabis as an “essential business” during the pandemic.
Livingston said it might be impossible to know if any industry is totally recession-proof, and certainly the coronavirus-spurred recession is unique.
“But what I think it shows more than anything for cannabis consumers is that cannabis is a staple commodity in their lives,” Livingston said. “Legal cannabis and good Netflix.”'
https://mjbizdaily.com/growing-marijiuana-markets-lift-earnings-for-multistate-operators/
'When announcing the close of its acquisition of Grassroots in July, Curaleaf proclaimed that it would create the largest cannabis company in the world.
Curaleaf already is at the top of the heap of U.S. marijuana MSOs, posting $121.4 million of revenue in the second quarter ended June 30.
Florida-based Trulieve and Illinois-based Green Thumb Industries were in almost identical territory, however, with $120.8 million and $119.6 million in revenue, respectively.'
https://mjbizdaily.com/curaleaf-rises-to-the-top-of-us-marijuana-industry-with-footprint-covering-about-two-dozen-states/
'Contracts between Germany’s Federal Institute for Drugs and Medical Devices and the three companies it tentatively selected to cultivate and distribute its medical cannabis could be formalized as early as Wednesday after a mandatory 10-day appeals process expires.
Ontario, Canada-based Wayland Group – through its joint venture with Berlin-based Demecan – and the German subsidiaries of Canadian companies Aphria and Aurora Cannabis were chosen earlier this month to provide product for what is one of the largest medical cannabis markets in the world. Each was evaluated based on a points system focused on infrastructure, quality standards, security plans and price.'
https://mjbizdaily.com/marijuana-business-this-week-german-medical-cannabis-contracts-cbd-self-regulation-mmj-groups-bank-account-closed-more/
'In fact, according to advocates of small cannabis businesses, if the sector evolves under the right conditions, craft will be the future of the marijuana sector.
Conversely, they say, under the wrong conditions, craft will perish and leave the space to a handful of cannabis conglomerates.'
https://mjbizdaily.com/craft-cannabis-is-the-marijuana-industrys-small-batch-sector/
'Although the Cannabis Act introduced a variety of classes of cannabis licences, including for smaller producers, the federal Government requires that a potential supplier have a production facility in place, meaning that the supplier will have already made a substantial investment prior to applying for a licence. Some have speculated that this has contributed to deterring small entrepreneurs from applying for licences and may have favoured the emergence of a market dominated or even monopolized by a relatively small number of large, multi-billion-dollar businesses. There have also been reports of the alcohol, tobacco and finance industries investing in companies involved in nonmedical cannabis production. For instance, according to media sources, in October 2017 Constellation Brands, a major international producer of wine, beer and spirits, invested $4 billion to acquire a 9.9 per cent stake in Canopy Growth, the leading Canadian producer, to develop cannabis-based beverages. By the end of December 2019, Constellation owned a 35 per cent stake in Canopy. In December 2018, the tobacco company Altria made a $1.8 million investment in Cronos Group, a cannabis production company, giving Altria a 45 per cent interest in Cronos. Earlier in the year, Molson Coors Brewing, another multinational alcohol company, signed a joint venture with Quebec-based HEXO to develop and market cannabis-infused beverages. Market analysts have predicted that the alcohol industry will also invest in companies that plan to produce beverages that combine cannabis and beer and, in particular, they predicted that by the end of 2019 two of the largest cannabis companies in the world would be owned by two of the largest alcohol and tobacco companies' - United Nations Office on Drugs and Crime, World Drug Report 2020, https://wdr.unodc.org/wdr2020/field/WDR20_BOOKLET_4.pdf
Ontario, Canada-based Wayland Group – through its joint venture with Berlin-based Demecan – and the German subsidiaries of Canadian companies Aphria and Aurora Cannabis were chosen earlier this month to provide product for what is one of the largest medical cannabis markets in the world. Each was evaluated based on a points system focused on infrastructure, quality standards, security plans and price.'
https://mjbizdaily.com/marijuana-business-this-week-german-medical-cannabis-contracts-cbd-self-regulation-mmj-groups-bank-account-closed-more/
'In fact, according to advocates of small cannabis businesses, if the sector evolves under the right conditions, craft will be the future of the marijuana sector.
Conversely, they say, under the wrong conditions, craft will perish and leave the space to a handful of cannabis conglomerates.'
https://mjbizdaily.com/craft-cannabis-is-the-marijuana-industrys-small-batch-sector/
'Although the Cannabis Act introduced a variety of classes of cannabis licences, including for smaller producers, the federal Government requires that a potential supplier have a production facility in place, meaning that the supplier will have already made a substantial investment prior to applying for a licence. Some have speculated that this has contributed to deterring small entrepreneurs from applying for licences and may have favoured the emergence of a market dominated or even monopolized by a relatively small number of large, multi-billion-dollar businesses. There have also been reports of the alcohol, tobacco and finance industries investing in companies involved in nonmedical cannabis production. For instance, according to media sources, in October 2017 Constellation Brands, a major international producer of wine, beer and spirits, invested $4 billion to acquire a 9.9 per cent stake in Canopy Growth, the leading Canadian producer, to develop cannabis-based beverages. By the end of December 2019, Constellation owned a 35 per cent stake in Canopy. In December 2018, the tobacco company Altria made a $1.8 million investment in Cronos Group, a cannabis production company, giving Altria a 45 per cent interest in Cronos. Earlier in the year, Molson Coors Brewing, another multinational alcohol company, signed a joint venture with Quebec-based HEXO to develop and market cannabis-infused beverages. Market analysts have predicted that the alcohol industry will also invest in companies that plan to produce beverages that combine cannabis and beer and, in particular, they predicted that by the end of 2019 two of the largest cannabis companies in the world would be owned by two of the largest alcohol and tobacco companies' - United Nations Office on Drugs and Crime, World Drug Report 2020, https://wdr.unodc.org/wdr2020/field/WDR20_BOOKLET_4.pdf
I love the 'widespread home growing' bit..now that is a move in the right direction...
'“A closer look at each country shows that one of the few commonalities across the continent is that most countries that legalized medical marijuana still have nonexistent or dysfunctional markets – sometimes even years after their cannabis laws were approved,” according to Marijuana Business Daily’s Latin America report, published in 2019.
“Restrictive access schemes, lack of health insurance coverage and widespread home growing moderate any initial excitement about the commercial opportunities in these markets.”'
https://mjbizdaily.com/canopy-growth-exits-cannabis-cultivation-on-3-continents-in-major-international-pullback/
'Over the past year, federally licensed medical cannabis producers like Peace Naturals, Tilray, and Tweed in Canada have exported to Germany, Croatia, New Zealand, Brazil, and Chile. In the Netherlands, the longtime cannabis company Bedrocan has shipped product to Canada, Australia, and European Union nations. Meanwhile, the Dutch government’s Office of Medicinal Cannabis sends shipments of medical marijuana to Italy, Germany, and Finland.'
https://www.leafly.com/news/industry/legal-international-cannabis-trade-already-exists-mapped
'Upon completion of the final regulatory steps, Columbia Care will be able to import, export, cultivate, process and distribute medical cannabis. With this Maltese license, Columbia Care is the first U.S. cannabis company authorized to operate in the European Union (EU) and will be able to access markets globally where federal medical cannabis programs exist.'
http://globenewswire.com/news-release/2018/11/15/1652235/0/en/Columbia-Care-Leads-US-Cannabis-Industry-Towards-Global-Expansion-By-Becoming-First-American-Company-Licensed-in-European-Union.html
'ICC is a leader in the South American cannabis market, and has over 70% market share in Uruguay, the first country in the world to legalize cannabis for adult consumer use. Besides this, the company also holds licenses in Colombia for the production of medical cannabis, and has an agreement to export cannabidiol products to Mexico and Brazil. Through this acquisition, Aurora will be able to leverage ICC’s market-leading position in South America, and aid the latter in its expansion plans.'
https://www.forbes.com/sites/greatspeculations/2018/09/11/aurora-cannabis-makes-inroads-into-south-america-with-latest-acquisition/
'“Today’s announcement marks another milestone for Tilray as we expand our global footprint and solidify our presence in Latin America by officially welcoming Alef to the Tilray team,” said Brendan Kennedy, President and Chief Executive Officer of Tilray. “The Chilean government has been a pioneer legitimizing and regulating medical cannabis in Latin America, and we are thrilled to be investing in one of the region’s most exciting markets for biopharmaceutical development.”'
https://www.businesswire.com/news/home/20181009005325/en/
'Cannabis for medical purposes was regulated in the Czech Republic, a country with approximately 10 million people, in 2013 and has since been legal as a prescribed form of medication. The law allows patients a total of 180 grams of dry flower product per month, as prescribed by specialized physicians, and can be obtained using an electronic prescription form. While the country has some domestic production, product availability remains limited and importing products from federally licensed producers with EU GMP cultivation facilities, like Aurora, will continue to augment supply and help meet growing market demand.'
https://www.newswire.ca/news-releases/aurora-cannabis-to-ship-medical-cannabis-to-the-czech-republic-701323691.html
'Marijuana Business Magazine spoke with the CEOs of four multistate businesses – Columbia Care, KushCo Holdings, MariMed and Organa Brands – to learn how they took their companies from single-state operators to marijuana industry behemoths with operations and/or products in 10 or more states.'
https://mjbizdaily.com/how-four-marijuana-companies-became-multistate-operators/
'CEO Bruce Linton issued a statement regarding Canopy’s intentional strategy of investing in the hemp opportunities over the last several years, citing the company’s “strategic acquisitions, infrastructure expansion, extensive internal research and development, strong supply of CBD, significant channel presence and intellectual property."
https://www.potnetwork.com/news/canopy-growth-enter-us-hemp-market-claiming-cbd-advantage
'Purchasing Natura would roughly double Tilray’s Canadian cultivation capacity, according to Cowen analyst Vivien Azer.
“The company’s supply agreements with third-party farmers continue to disappoint on product quality,” she wrote in an investor note. “The Natura transaction will allow TLRY to significantly expand its capacity.”'
https://mjbizdaily.com/tilray-buy-canadian-cannabis-cultivator-double-domestic-footprint/
'It’s a no-brainer for Canadian companies to ratchet up involvement in the U.S. hemp because of the 2018 Farm Bill, said Russ Crawford, president of the Canadian Hemp Trade Alliance.
That’s because hemp’s new legal status makes it an obvious route to finding U.S. consumers.
The Farm Bill is going to push the market for hemp-derived CBD in the U.S. to at least $6.1 billion by 2023, according to Hemp Industry Daily’s Special Report, 2018 Farm Bill: What’s Next For Hemp?
Canadian marijuana companies no longer endanger their positions on U.S. trading exchanges as long as they enter the country through hemp products.'
https://hempindustrydaily.com/canada-marijuana-titans-u-s-hemp-industry/
'Clever Leaves met all the requirements of Health Canada to obtain the import permit, which demonstrates the high quality of its cultivation practices, extraction facilities, operating procedures, and management team. The company is currently cultivating medical cannabis in the first phase of a 1.5 million square foot agricultural production facility.
Colombia has worked diligently in recent years to become one of the most sophisticated and comprehensive medical cannabis markets in the Southern Hemisphere. With a clear regulatory framework and the potential for large-scale, low-cost production, Colombia could become one of the largest global export leaders of medical cannabis. '
https://www.prnewswire.com/news-releases/clever-leaves-first-colombian-company-to-export-medical-cannabis-to-canada-300791430.html
'Instead of acquiring an existing hemp company like Aurora and Tilray, Canopy Growth seems to be laying the groundwork for setting up its hemp infrastructure. Late last month, Canopy announced that it had received licensing to cultivate and process hemp in the state of New York. So far, Canopy has pledged to invest $500 million in its hemp production capacity, and hopes to expand its hemp footprint to two more states.
While regulators continue to grapple with the question of how to regulate CBD, the cannabis industry is betting big on hemp-CBD. Though no clear leader in this sector has yet emerged, one thing is certain: The hemp and cannabis segments are becoming increasingly intertwined.'
https://newfrontierdata.com/marijuana-insights/cannabis-companies-beginning-to-ante-up-for-bets-on-hemp/
'The brothers were still focused on medical marijuana as a business, but that changed in August 2013 when CNN’s Sanjay Gupta did a special on their success with Charlotte. Fifteen thousand families reached out to them in the next month, they said, and the company decided to focus on CBD. Charlotte’s Web was born.
According to the company, sales have tripled every year since 2015. It currently ranks No. 1 in the world for sales of hemp-based CBD, according to New Cannabis Ventures, an information platform focused on the cannabis industry. In September, in Canada, the company raised $100 million in an I.P.O. '
https://www.nytimes.com/2019/03/06/style/cbd-charlottes-web-seven-brothers.html
'Aurora is the medical cannabis market leader in Germany. The Company has supplied the German market with dried cannabis flower via Aurora Deutschland (formerly Pedanios) since December 2015, and with Canadian-grown Aurora products since September 2017. Aurora has established a strong brand as a trusted supplier among prescribing physicians, dispensing pharmacies, and German patients. As one of few companies able to sell oils in this rapidly growing market, Aurora is well positioned to establish brand leadership in the European derivatives market.'
https://www.prnewswire.com/news-releases/aurora-commences-cannabis-oil-sales-to-german-pharmacies-300809723.html
'Countries such as Poland, France and Ireland represent nascent opportunities for medical marijuana, along with more mature markets in the European Union such as Cyprus, the Czech Republic, the United Kingdom and Germany – where Kennedy said he expects 100,000 patients by the end of the year compared with just 800 at the end of 2015.
Net loss for the full year 2018 totaled $67.7 million amid annual revenue of $43.1 million, more than double that period in 2017.'
https://mjbizdaily.com/marijuana-firm-tilray-reports-higher-than-expected-q4-revenue-of-15-5m/
'Perhaps what’s most exciting about the cannabis industry right now is that there aren’t any major players yet. Those companies looking to dominate the market should consider prioritizing their financials, marketing and growth strategy, branding, and hiring strategy. Those factors, while critical to the success of any business, will be integral in attracting top candidates and determining which cannabis brands will become the most recognized companies of tomorrow.'
https://www.forbes.com/sites/forbescommunicationscouncil/2019/03/18/how-to-determine-if-a-cannabis-company-is-well-positioned-to-scale/
'Yet another cannabis company has reported strong sales growth following the legalization of recreational pot in Canada.
Cronos Group (CRON), which has the financial backing of Marlboro owner Altria (MO), said Tuesday that revenue in its most recent quarter soared 248% compared with the same period a year ago. The news follows similarly solid sales increases from rivals Canopy Growth (CGC), Aurora (ACB) and Tilray (TLRY).'
https://edition.cnn.com/business/live-news/stock-market-news-today-032619/h_c580acae1a82a390487c630cf074afa5
'Hilary explains the far reaching impacts of Washington States historic 502 initiative, legalizing marijuana for recreational use. She explores the complex issues pertaining to big business entering into the marijuana industry.'
https://www.youtube.com/watch?v=0M4Fse1Ioaw
'Acreage Holdings, a multistate cannabis company based in New York, is planning to go public in Canada via a reverse takeover, becoming the latest U.S. marijuana business to get its shares listed north of the border through an RTO.'
https://mjbizdaily.com/multistate-marijuana-firm-acreage-holdings-to-go-public-in-canada-via-reverse-takeover/
No comments:
Post a Comment